Bright key facts / Experimental
An exoskeleton moves into clinical testing.
Wandercraft’s personal exoskeleton entered a clinical trial, with NVIDIA reporting simulation and AI use in its development.
- AI’s role
- Simulation helps developers train and test robotic control before physical trials.
- Documented result
- NVIDIA reported trial activity for the self-balancing personal exoskeleton.
- Important limitation
- A clinical trial is not a demonstrated recovery, universal walking result or approval for every use.